News
Latest News
- 05 Aug 2020 – Neil Clark, CEO, interviewed by Equity Development
- 27 July 2020 – Update on Phase 2b clinical study of XF-73
- 10 July 2020 – Pharma companies join forces to launch $1 billion fund to develop new antibiotics by 2030
- 10 June 2020 – Result of Annual General Meeting
- 09 June 2020 – Grant awarded for Cardiff University collaboration
- 12 May 2020 – Posting of Annual Report and Notice of AGM
- 07 May 2020 – Director of Preclinical Development as panel member for KTN Antimicrobial Resistance Global Expert Mission dissemination seminar
- 06 May 2020 – FT article highlights Coronavirus lessons for the fight against superbugs
- 04 May 2020 – Independent review supports the potential of XF-73
- 29 Apr 2020 – Audited results for the year ended 31 December 2019 and clinical development update